公开(公告)号：US07320859B2

公开(公告)日：2008-01-22

申请号：US10466368

申请日：2002-01-10

申请人： Hanns-Martin Schmidt ,  Ludger Altrogge ,  Dietmar Lenz ,  Gudula Riemen ,  Helmut Brosterhus ,  Elke Lorbach ,  Juliana Helfrich ,  Katharina Hein ,  Marion Gremse ,  Tatjana Males ,  Rainer Christine ,  Gregor Siebenkotten ,  Bodo Ortmann ,  Tamara Turbanski ,  Andreas Klaes

发明人： Hanns-Martin Schmidt ,  Ludger Altrogge ,  Dietmar Lenz ,  Gudula Riemen ,  Helmut Brosterhus ,  Elke Lorbach ,  Juliana Helfrich ,  Katharina Hein ,  Marion Gremse ,  Tatjana Males ,  Rainer Christine ,  Gregor Siebenkotten ,  Bodo Ortmann ,  Tamara Turbanski ,  Andreas Klaes

IPC分类号： C12Q1/68

CPC分类号： C07K14/47 ,  A61K48/00 ,  C07K2319/035 ,  C07K2319/09 ,  C07K2319/10 ,  C07K2319/21 ,  C12N15/87

摘要： The present invention relates to a method for transfection of cells using at least one protein capable of forming nucleoprotein filaments, wherein the protein is initially modified with at least one functional component which influences one or more steps of the transfection, the nucleic acid to be transfected is then loaded with the modified protein, whereby the nucleic acid and the protein form a filament-like complex, and this complex is finally added to the cells to be transfected. The invention further relates to a transfection agent consisting of nucleoprotein filaments (NPF), with at least one nucleoprotein filament-forming protein being modified with at least one functional component for the transfection. Furthermore, the present invention relates to the use of the transfection agent according to the invention for producing a drug for gene therapeutic treatment of humans and animals. The present inventions also includes corresponding pharmaceutical preparations, especially for use in gene therapy as well as the use of such transfection agents as component in kits.

摘要翻译： 本发明涉及使用至少一种能够形成核蛋白长丝的蛋白质转染细胞的方法，其中蛋白质最初用至少一种影响转染一个或多个步骤的功能成分修饰，待转染的核酸 然后加载修饰的蛋白质，由此核酸和蛋白质形成丝状复合物，并将该复合物最终加入待转染的细胞中。 本发明还涉及由核蛋白丝（NPF）组成的转染剂，至少一种核蛋白长丝形成蛋白被至少一个用于转染的功能组分修饰。 此外，本发明涉及根据本发明的转染剂用于生产用于人和动物基因治疗的药物的用途。 本发明还包括相应的药物制剂，特别是用于基因治疗以及使用这样的转染剂作为试剂盒中的组分。